Senti Biosciences | 8-K: Senti Bio Announces Second Quarter 2024 Results and Reviews Recent Corporate and Pipeline Highlights
Senti Biosciences | 8-K: Current report
Senti Biosciences | 8-K: Current report
Senti Biosciences | 8-K: Current report
Senti Biosciences | DEF 14A: Definitive information statements
Senti Biosciences | DEFA14A: Others
Senti Biosciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Senti Biosciences | 8-K: Current report
Senti Biosciences | 8-K: Senti Bio Announces First Quarter 2024 Results and Reviews Recent Corporate Highlights
Senti Biosciences | 8-K: Current report
Senti Biosciences | 8-K: Current report
Senti Biosciences | 8-K: Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights
Senti Biosciences | 8-K: Current report
Senti Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Senti Biosciences | 8-K: Current report
Senti Biosciences | 8-K: Current report
Senti Biosciences | 8-K: Senti Bio Announces Third Quarter 2023 Results and Pipeline Updates
Senti Biosciences | 8-K: Current report
Senti Biosciences | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Senti Biosciences | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
No Data